Skip to main content
SpringerLink
Log in

BPH drugs may increase high-grade prostate cancer risk

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Health Canada.Finasteride (Proscar, Propecia) and dutasteride (Avodart, Jalyn): may increase the risk of high-grade prostate cancer. Media Release: 19 Mar 2012. Available from: URL: http://www.hc-sg.gc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

BPH drugs may increase high-grade prostate cancer risk. React. Wkly. 1394, 1 (2012). https://doi.org/10.2165/00128415-201213940-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213940-00001

Keywords

Search

Navigation